CC
AVNR

Columbia Capital’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Columbia Capital’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$1.15M Buy
+67,583
New +$951K 1.25% 11

Other funds holding AVNR

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Columbia Capital's AVNR Position: Q4 2014 in Review

Columbia Capital opened a new position in AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q4 2014: 67,583 shares worth $1.15M. The stake represents 1.25% of the portfolio and ranks #11 among its holdings.

166 funds tracked by Wall St. Rank hold AVNR as of Q4 2014.

  • Columbia Capital held 67,583 shares of AVANIR PHARMACEUTICALS, INC CL A worth $1.15M as of Q4 2014.
  • AVANIR PHARMACEUTICALS, INC CL A was a new Columbia Capital position in Q4 2014.
  • AVANIR PHARMACEUTICALS, INC CL A made up 1.25% of Columbia Capital's portfolio in Q4 2014, its #11 holding.
  • 166 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q4 2014.

Based on Columbia Capital's 13F filing for Q4 2014, filed 11 Feb 2015.